THIS IS AN EDUCATIONAL COMMUNITY BASED SUPPORT FORUM FOR HARM MINIMIZATION ONLY.
NO SOURCING OR DEALING WILL BE TOLERATED.
TO USE THIS WEBSITE YOU MUST READ AND AGREE TO THESE RULES HERE.
MEMBERS THAT DO NOT FOLLOW THE RULES WILL BE AGGRESSIVELY BANNED.
Page 6 of 6 FirstFirst ... 456
Results 51 to 58 of 58

Thread: Smoking again

  1. #51
    Join Date
    Dec 2016
    Posts
    72
    Thanks
    1
    Thanked 9 Times in 7 Posts

    Default

    Quote Originally Posted by Daz69 View Post
    Little Cunt...

    Oh dear it appears that daz is having a stroke. His vocabulary has been reduced to two words. Best of luck buddy hope you get well soon!

  2. #52
    Join Date
    Nov 2017
    Posts
    1
    Thanks
    0
    Thanked 0 Times in 0 Posts

    Default

    Been in Vegas for about a year now and don't have a big social circle. Back home in Canada it's quite easy to get ahold of weed. I know it's against the rules but any advice or contacts would be appreciated. Feel free to shoot me a message or email if anyone can help out.

    Thanks Folks!

  3. #53
    Join Date
    Dec 2016
    Posts
    72
    Thanks
    1
    Thanked 9 Times in 7 Posts

    Default

    Quote Originally Posted by Divo View Post
    Been in Vegas for about a year now and don't have a big social circle. Back home in Canada it's quite easy to get ahold of weed. I know it's against the rules but any advice or contacts would be appreciated. Feel free to shoot me a message or email if anyone can help out.

    Thanks Folks!
    https://weedmaps.com/earth/us/nv/north-las-vegas/89031

    SOLMFAO Why would it be aganst the rules to get the location on the closest legal cannabis shop? Just use the app and go to the closest store what could be easier? So why are you having a hard time finding weed Daz opps Divo?

    FYI recreational cannabis became legal in Vegas on January 1st 2017 but you would know that living in Vegas eh Divo Daz? its only been headline news for the past year. http://money.cnn.com/2017/03/30/news...ada/index.html

    And now Daz will claim I have broken the rules. SOLMFAO those rules only apply to New Zealanders and not where cannabis is legal. Next time do a little research Daz Or Divo or whatever your calling yourself now.
    Last edited by Rider420; 19-11-2017 at 08:46 AM.

  4. #54
    Join Date
    Aug 2011
    Location
    Dead for tax purposes
    Posts
    422
    Thanks
    199
    Thanked 305 Times in 164 Posts

    Default

    Quote Originally Posted by Rider420 View Post
    https://weedmaps.com/earth/us/nv/north-las-vegas/89031

    SOLMFAO Why would it be aganst the rules to get the location on the closest legal cannabis shop? Just use the app and go to the closest store what could be easier? So why are you having a hard time finding weed Daz opps Divo?

    FYI recreational cannabis became legal in Vegas on January 1st 2017 but you would know that living in Vegas eh Divo Daz? its only been headline news for the past year. http://money.cnn.com/2017/03/30/news...ada/index.html

    And now Daz will claim I have broken the rules. SOLMFAO those rules only apply to New Zealanders and not where cannabis is legal. Next time do a little research Daz Or Divo or whatever your calling yourself now.
    I've presented you with more than sufficient research to show Cannabis abuse (via smoking) could cause deleterious changes to pulmonary tissues over the longer term, and neurological changes in adolescents..

    You seem unable to present rational argument for both points:

    . Deleterious changes to pulmonary tissues
    . Neurological changes in adolescents



    "Our entire universe is contained in the mind and the spirit. We may choose not to find access to it, we may even deny its existence, but it is indeed there inside us "... Dr Alexander Shulgin June 17th, 1925-June 2nd, 2014.

  5. #55
    Join Date
    Dec 2016
    Posts
    72
    Thanks
    1
    Thanked 9 Times in 7 Posts

    Default

    Quote Originally Posted by Daz69 View Post
    I've presented you with more than sufficient research to show Cannabis abuse (via smoking) could cause deleterious changes to pulmonary tissues over the longer term, and neurological changes in adolescents..

    You seem unable to present rational argument for both points:

    . Deleterious changes to pulmonary tissues
    . Neurological changes in adolescents



    It is impossible to defeat an ignorant man in argument.

    You have reefer madness Daz you believe in theories rather then facts, where is your proof? I have agreed that smoking a lot of cannabis every day will give you a smokers cough but not lung diseases or lung cancer. As far as kids smoking cannabis well we all agree that they should wait until legal age but that said the adolescent medical cannabis users that have been studied in Canada have not shown any negative neurological changes.

    So which are facts theories or studies from real world patients?

    Good luck Dazed you need it.

  6. #56
    Join Date
    Dec 2016
    Posts
    72
    Thanks
    1
    Thanked 9 Times in 7 Posts

    Default

    Poor daz he does not seem to understand the difference between facts and theories.

    He quotes theories that state if cannabis is as harmful as tobacco it has the potential to kill half of its users. However if that was a fact we would see hundreds of thousands of deaths by cannabis by now. Sadly Daz can't quite understand the difference between theories and empirical facts.

    Daz quotes theories based on statistics that kids who are dumb enough to get caught smoking weed tend to be less intelligent then those who don't get caught as adults. What came first the chicken or the egg in other words are people who get caught are dumber then those who don't or is the NARCS theory that smoking weed causes damage to the brain making those who get caught dumber. Simpsons paradox.

    Fact is 7 million die from alcohol 3 million from booze hundreds from aspirin so what's safer smoking a joint of cannabis that has never had a death or aspirin? But poor Daz thinks cannabis is a dangerous and harmful drug. Sad really no pathetic considering the Divo move oh well stupidity and cowardice is its own reward.

  7. #57
    Join Date
    Aug 2011
    Location
    Dead for tax purposes
    Posts
    422
    Thanks
    199
    Thanked 305 Times in 164 Posts

    Default

    Theory: a supposition or a system of ideas intended to explain something, especially one based on general principles independent of the thing to be explained.


    Clinical research: is a branch of healthcare science that determines the safety and effectiveness (efficacy) of medications, devices, diagnostic products and treatment regimens intended for human use. These may be used for prevention, treatment, diagnosis or for relieving symptoms of a disease.

    Clinical trials: are research studies that explore whether a medical strategy, treatment, or device is safe and effective for humans. These studies also may show which medical approaches work best for certain illnesses or groups of people.

    Types of Study Designs:
    . Meta-Analysis. A way of combining data from many different research studies. ...
    . Systematic Review. ...
    . Randomized Controlled Trial. ...
    . Cohort Study (Prospective Observational Study) ...
    . Case-control Study. ...
    . Cross-sectional study. ...
    . Case Reports and Series. ...
    . Ideas, Editorials, Opinions.

    Timberlake DS. A comparison of drug use and dependence between blunt smokers and other cannabis users. Subst Use Misuse. 2009;44(3):401-415. doi:10.1080/10826080802347651.

    Mehmedic Z, Chandra S, Slade D, et al. Potency trends of Δ9-THC and other cannabinoids in confiscated cannabis preparations from 1993 to 2008. J Forensic Sci. 2010;55(5):1209-1217. doi:10.1111/j.1556-4029.2010.01441.x.

    Results from the 2015 National Survey on Drug Use and Health: Detailed Tables, SAMHSA, CBHSQ. http://www.samhsa.gov/data/sites/def...tTabs-2015.htm. Accessed October 11, 2016.

    Carliner H, Mauro PM, Brown QL, et al. The widening gender gap in marijuana use prevalence in the U.S. during a period of economic change, 2002-2014. Drug Alcohol Depend. 2016;170:51-58. doi:10.1016/j.drugalcdep.2016.10.042.

    Johnston L, O’Malley P, Miech R, Bachman J, Schulenberg J. Monitoring the Future National Survey Results on Drug Use: 1975-2016: Overview: Key Findings on Adolescent Drug Use. Ann Arbor, MI: Institute for Social Research, The University of Michigan; 2016.

    Center for Behavioral Health Statistics and Quality (CBHSQ). Drug Abuse Warning Network: 2011: Selected Tables of National Estimates of Drug-Related Emergency Department Visits. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2013.

    Lenné MG, Dietze PM, Triggs TJ, Walmsley S, Murphy B, Redman JR. The effects of cannabis and alcohol on simulated arterial driving: Influences of driving experience and task demand. Accid Anal Prev. 2010;42(3):859-866. doi:10.1016/j.aap.2009.04.021.

    Hartman RL, Huestis MA. Cannabis effects on driving skills. Clin Chem. 2013;59(3):478-492. doi:10.1373/clinchem.2012.194381.

    Hartman RL, Brown TL, Milavetz G, et al. Cannabis effects on driving lateral control with and without alcohol. Drug Alcohol Depend. 2015;154:25-37. doi:10.1016/j.drugalcdep.2015.06.015.

    Brady JE, Li G. Trends in Alcohol and Other Drugs Detected in Fatally Injured Drivers in the United States, 1999–2010. Am J Epidemiol. January 2014:kwt327. doi:10.1093/aje/kwt327.

    Biecheler M-B, Peytavin J-F, Sam Group, Facy F, Martineau H. SAM survey on “drugs and fatal accidents”: search of substances consumed and comparison between drivers involved under the influence of alcohol or cannabis. Traffic Inj Prev. 2008;9(1):11-21. doi:10.1080/15389580701737561.

    DRUID Final Report: Work Performed, Main Results and Recommendations. EU DRUID Programme; 2012. http://www.roadsafetyobservatory.com.../Details/10940.

    Elvik R. Risk of road accident associated with the use of drugs: a systematic review and meta-analysis of evidence from epidemiological studies. Accid Anal Prev. 2013;60:254-267. doi:10.1016/j.aap.2012.06.017.

    Ramaekers JG, Berghaus G, van Laar M, Drummer OH. Dose related risk of motor vehicle crashes after cannabis use. Drug Alcohol Depend. 2004;73(2):109-119.

    Li M-C, Brady JE, DiMaggio CJ, Lusardi AR, Tzong KY, Li G. Marijuana Use and Motor Vehicle Crashes. Epidemiol Rev. 2012;34(1):65-72. doi:10.1093/epirev/mxr017.

    Asbridge M, Hayden JA, Cartwright JL. Acute cannabis consumption and motor vehicle collision risk: systematic review of observational studies and meta-analysis. BMJ. 2012;344:e536. doi:10.1136/bmj.e536.

    Compton RP, Berning A. Drug and Alcohol Crash Risk. Washington, DC: National Highway Traffic Safety Administration; 2015. DOT HA 812 117.

    Hasin DS, Saha TD, Kerridge BT, et al. Prevalence of Marijuana Use Disorders in the United States Between 2001-2002 and 2012-2013. JAMA Psychiatry. 2015;72(12):1235-1242. doi:10.1001/jamapsychiatry.2015.1858.

    Winters KC, Lee C-YS. Likelihood of developing an alcohol and cannabis use disorder during youth: Association with recent use and age. Drug Alcohol Depend. 2008;92(1-3):239-247. doi:10.1016/j.drugalcdep.2007.08.005.

    Budney AJ, Hughes JR. The cannabis withdrawal syndrome. Curr Opin Psychiatry. 2006;19(3):233-238. doi:10.1097/01.yco.0000218592.00689.e5.

    Gorelick DA, Levin KH, Copersino ML, et al. Diagnostic Criteria for Cannabis Withdrawal Syndrome. Drug Alcohol Depend. 2012;123(1-3):141-147. doi:10.1016/j.drugalcdep.2011.11.007.

    Rotter A, Bayerlein K, Hansbauer M, et al. CB1 and CB2 receptor expression and promoter methylation in patients with cannabis dependence. Eur Addict Res. 2013;19(1):13-20. doi:10.1159/000338642.

    Morgan CJA, Page E, Schaefer C, et al. Cerebrospinal fluid anandamide levels, cannabis use and psychotic-like symptoms. Br J Psychiatry J Ment Sci. 2013;202(5):381-382. doi:10.1192/bjp.bp.112.121178.

    Anthony JC, Warner LA, Kessler RC. Comparative epidemiology of dependence on tobacco, alcohol, controlled substances, and inhalants: Basic findings from the National Comorbidity Survey. Exp Clin Psychopharmacol. 1994;2(3):244-268. doi:10.1037/1064-1297.2.3.244.

    Lopez-Quintero C, Pérez de los Cobos J, Hasin DS, et al. Probability and predictors of transition from first use to dependence on nicotine, alcohol, cannabis, and cocaine: results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Drug Alcohol Depend. 2011;115(1-2):120-130. doi:10.1016/j.drugalcdep.2010.11.004.

    Anthony JC. The epidemiology of cannabis dependence. In: Roffman RA, Stephens RS, eds. Cannabis Dependence: Its Nature, Consequences and Treatment. Cambridge, UK: Cambridge University Press; 2006:58-105.

    Hall WD, Pacula RL. Cannabis Use and Dependence: Public Health and Public Policy. Cambridge, UK: Cambridge University Press; 2003.

    Center for Behavioral Health Statistics and Quality (CBHSQ). Treatment Episode Data Set (TEDS): 2003-2013. National Admissions to Substance Abuse Treatment Services. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2015. BHSIS Series S-75, HHS Publication No. (SMA) 15-4934.

    Office of National Drug Control Policy. National Drug Control Strategy: Data Supplement 2015. https://www.whitehouse.gov/sites/def...ment_final.pdf. Published 2015. Accessed January 5, 2017.

    Freeman TP, Morgan CJA, Hindocha C, Schafer G, Das RK, Curran HV. Just say “know”: how do cannabinoid concentrations influence users’ estimates of cannabis potency and the amount they roll in joints? Addict Abingdon Engl. 2014;109(10):1686-1694. doi:10.1111/add.12634.

    van der Pol P, Liebregts N, Brunt T, et al. Cross-sectional and prospective relation of cannabis potency, dosing and smoking behaviour with cannabis dependence: an ecological study. Addict Abingdon Engl. 2014;109(7):1101-1109. doi:10.1111/add.12508.

    Campolongo P, Trezza V, Cassano T, et al. Perinatal exposure to delta-9-tetrahydrocannabinol causes enduring cognitive deficits associated with alteration of cortical gene expression and neurotransmission in rats. Addict Biol. 2007;12(3-4):485-495. doi:10.1111/j.1369-1600.2007.00074.x.

    Antonelli T, Tomasini MC, Tattoli M, et al. Prenatal exposure to the CB1 receptor agonist WIN 55,212-2 causes learning disruption associated with impaired cortical NMDA receptor function and emotional reactivity changes in rat offspring. Cereb Cortex N Y N 1991. 2005;15(12):2013-2020. doi:10.1093/cercor/bhi076.

    Verrico CD, Gu H, Peterson ML, Sampson AR, Lewis DA. Repeated Δ9-tetrahydrocannabinol exposure in adolescent monkeys: persistent effects selective for spatial working memory. Am J Psychiatry. 2014;171(4):416-425. doi:10.1176/appi.ajp.2013.13030335.

    Rubino T, Realini N, Braida D, et al. Changes in hippocampal morphology and neuroplasticity induced by adolescent THC treatment are associated with cognitive impairment in adulthood. Hippocampus. 2009;19(8):763-772. doi:10.1002/hipo.20554.

    Gleason KA, Birnbaum SG, Shukla A, Ghose S. Susceptibility of the adolescent brain to cannabinoids: long-term hippocampal effects and relevance to schizophrenia. Transl Psychiatry. 2012;2:e199. doi:10.1038/tp.2012.122.

    Quinn HR, Matsumoto I, Callaghan PD, et al. Adolescent rats find repeated Delta(9)-THC less aversive than adult rats but display greater residual cognitive deficits and changes in hippocampal protein expression following exposure. Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol. 2008;33(5):1113-1126. doi:10.1038/sj.npp.1301475.

    Batalla A, Bhattacharyya S, Yücel M, et al. Structural and functional imaging studies in chronic cannabis users: a systematic review of adolescent and adult findings. PloS One. 2013;8(2):e55821. doi:10.1371/journal.pone.0055821.

    Filbey FM, Aslan S, Calhoun VD, et al. Long-term effects of marijuana use on the brain. Proc Natl Acad Sci U S A. 2014;111(47):16913-16918. doi:10.1073/pnas.1415297111.

    Pagliaccio D, Barch DM, Bogdan R, et al. Shared predisposition in the association between cannabis use and subcortical brain structure. JAMA Psychiatry. 2015;72(10):994-1001. doi:10.1001/jamapsychiatry.2015.1054.

    Volkow ND, Swanson JM, Evins AE, et al. Effects of cannabis use on human behavior, including cognition, motivation, and psychosis: a review. JAMA Psychiatry. 2016;73(3):292-297. doi:10.1001/jamapsychiatry.2015.3278.

    Auer R, Vittinghoff E, Yaffe K, et al. Association between lifetime marijuana use and cognitive function in middle age: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. JAMA Intern Med. February 2016. doi:10.1001/jamainternmed.2015.7841.
    Meier MH, Caspi A, Ambler A, et al. Persistent cannabis users show neuropsychological decline from childhood to midlife. Proc Natl Acad Sci U S A. 2012;109(40):E2657-E2664. doi:10.1073/pnas.1206820109.

    Rubino T, Zamberletti E, Parolaro D. Adolescent exposure to cannabis as a risk factor for psychiatric disorders. J Psychopharmacol Oxf Engl. 2012;26(1):177-188. doi:10.1177/0269881111405362.

    Jackson NJ, Isen JD, Khoddam R, et al. Impact of adolescent marijuana use on intelligence: Results from two longitudinal twin studies. Proc Natl Acad Sci U S A. 2016;113(5):E500-E508. doi:10.1073/pnas.1516648113.

    Secades-Villa R, Garcia-Rodríguez O, Jin CJ, Wang S, Blanco C. Probability and predictors of the cannabis gateway effect: a national study. Int J Drug Policy. 2015;26(2):135-142. doi:10.1016/j.drugpo.2014.07.011.

    Weinberger AH, Platt J, Goodwin RD. Is cannabis use associated with an increased risk of onset and persistence of alcohol use disorders? A three-year prospective study among adults in the United States. Drug Alcohol Depend. February 2016. doi:10.1016/j.drugalcdep.2016.01.014.

    Pistis M, Perra S, Pillolla G, Melis M, Muntoni AL, Gessa GL. Adolescent exposure to cannabinoids induces long-lasting changes in the response to drugs of abuse of rat midbrain dopamine neurons. Biol Psychiatry. 2004;56(2):86-94. doi:10.1016/j.biopsych.2004.05.006.

    Agrawal A, Neale MC, Prescott CA, Kendler KS. A twin study of early cannabis use and subsequent use and abuse/dependence of other illicit drugs. Psychol Med. 2004;34(7):1227-1237.

    Panlilio LV, Zanettini C, Barnes C, Solinas M, Goldberg SR. Prior exposure to THC increases the addictive effects of nicotine in rats. Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol. 2013;38(7):1198-1208. doi:10.1038/npp.2013.16.

    Cadoni C, Pisanu A, Solinas M, Acquas E, Di Chiara G. Behavioural sensitization after repeated exposure to Delta 9-tetrahydrocannabinol and cross-sensitization with morphine. Psychopharmacology (Berl). 2001;158(3):259-266. doi:10.1007/s002130100875.

    Levine A, Huang Y, Drisaldi B, et al. Molecular mechanism for a gateway drug: epigenetic changes initiated by nicotine prime gene expression by cocaine. Sci Transl Med. 2011;3(107):107ra109. doi:10.1126/scitranslmed.3003062.

    Schweinsburg AD, Brown SA, Tapert SF. The influence of marijuana use on neurocognitive functioning in adolescents. Curr Drug Abuse Rev. 2008;1(1):99-111.

    Macleod J, Oakes R, Copello A, et al. Psychological and social sequelae of cannabis and other illicit drug use by young people: a systematic review of longitudinal, general population studies. Lancet Lond Engl. 2004;363(9421):1579-1588. doi:10.1016/S0140-6736(04)16200-4.

    Silins E, Horwood LJ, Patton GC, et al. Young adult sequelae of adolescent cannabis use: an integrative analysis. Lancet Psychiatry. 2014;1(4):286-293. doi:10.1016/S2215-0366(14)70307-4.

    Fergusson DM, Boden JM. Cannabis use and later life outcomes. Addict Abingdon Engl. 2008;103(6):969-976; discussion 977-978. doi:10.1111/j.1360-0443.2008.02221.x.

    Brook JS, Lee JY, Finch SJ, Seltzer N, Brook DW. Adult work commitment, financial stability, and social environment as related to trajectories of marijuana use beginning in adolescence. Subst Abuse. 2013;34(3):298-305. doi:10.1080/08897077.2013.775092.

    McCaffrey DF, Pacula RL, Han B, Ellickson P. Marijuana Use and High School Dropout: The Influence of Unobservables. Health Econ. 2010;19(11):1281-1299. doi:10.1002/hec.1561.

    Gruber AJ, Pope HG, Hudson JI, Yurgelun-Todd D. Attributes of long-term heavy cannabis users: a case-control study. Psychol Med. 2003;33(8):1415-1422.

    Macdonald S, Hall W, Roman P, Stockwell T, Coghlan M, Nesvaag S. Testing for cannabis in the work-place: a review of the evidence. Addict Abingdon Engl. 2010;105(3):408-416. doi:10.1111/j.1360-0443.2009.02808.x.

    Zwerling C, Ryan J, Orav EJ. The efficacy of preemployment drug screening for marijuana and cocaine in predicting employment outcome. JAMA. 1990;264(20):2639-2643.

    Radhakrishnan R, Wilkinson ST, D’Souza DC. Gone to Pot - A Review of the Association between Cannabis and Psychosis. Front Psychiatry. 2014;5:54. doi:10.3389/fpsyt.2014.00054.

    Blanco C, Hasin DS, Wall MM, et al. Cannabis Use and Risk of Psychiatric Disorders: Prospective Evidence From a US National Longitudinal Study. JAMA Psychiatry. February 2016. doi:10.1001/jamapsychiatry.2015.3229.

    Di Forti M, Iyegbe C, Sallis H, et al. Confirmation that the AKT1 (rs2494732) genotype influences the risk of psychosis in cannabis users. Biol Psychiatry. 2012;72(10):811-816. doi:10.1016/j.biopsych.2012.06.020.

    Caspi A, Moffitt TE, Cannon M, et al. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction. Biol Psychiatry. 2005;57(10):1117-1127. doi:10.1016/j.biopsych.2005.01.026.

    Delforterie MJ, Lynskey MT, Huizink AC, et al. The relationship between cannabis involvement and suicidal thoughts and behaviors. Drug Alcohol Depend. 2015;150:98-104. doi:10.1016/j.drugalcdep.2015.02.019.

    Borges G, Bagge CL, Orozco R. A literature review and meta-analyses of cannabis use and suicidality. J Affect Disord. 2016;195:63-74. doi:10.1016/j.jad.2016.02.007.

    Tashkin DP. Effects of marijuana smoking on the lung. Ann Am Thorac Soc. 2013;10(3):239-247. doi:10.1513/AnnalsATS.201212-127FR.

    Owen KP, Sutter ME, Albertson TE. Marijuana: respiratory tract effects. Clin Rev Allergy Immunol. 2014;46(1):65-81. doi:10.1007/s12016-013-8374-y.

    Polen MR, Sidney S, Tekawa IS, Sadler M, Friedman GD. Health care use by frequent marijuana smokers who do not smoke tobacco. West J Med. 1993;158(6):596-601.

    Hashibe M, Morgenstern H, Cui Y, et al. Marijuana use and the risk of lung and upper aerodigestive tract cancers: results of a population-based case-control study. Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol. 2006;15(10):1829-1834. doi:10.1158/1055-9965.EPI-06-0330.

    Hancox RJ, Poulton R, Ely M, et al. Effects of cannabis on lung function: a population-based cohort study. Eur Respir J. 2010;35(1):42-47. doi:10.1183/09031936.00065009.

    Mittleman MA, Lewis RA, Maclure M, Sherwood JB, Muller JE. Triggering Myocardial Infarction by Marijuana. Circulation. 2001;103(23):2805-2809. doi:10.1161/01.CIR.103.23.2805.

    Thomas G, Kloner RA, Rezkalla S. Adverse cardiovascular, cerebrovascular, and peripheral vascular effects of marijuana inhalation: what cardiologists need to know. Am J Cardiol. 2014;113(1):187-190. doi:10.1016/j.amjcard.2013.09.042.

    Jones RT. Cardiovascular system effects of marijuana. J Clin Pharmacol. 2002;42(11 Suppl):58S - 63S.

    Lacson JCA, Carroll JD, Tuazon E, Castelao EJ, Bernstein L, Cortessis VK. Population-based case-control study of recreational drug use and testis cancer risk confirms an association between marijuana use and nonseminoma risk. Cancer. 2012;118(21):5374-5383. doi:10.1002/cncr.27554.

    Daling JR, Doody DR, Sun X, et al. Association of marijuana use and the incidence of testicular germ cell tumors. Cancer. 2009;115(6):1215-1223. doi:10.1002/cncr.24159.

    Bachhuber MA, Saloner B, Cunningham CO, Barry CL. Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999-2010. JAMA Intern Med. 2014;174(10):1668-1673. doi:10.1001/jamainternmed.2014.4005.

    Finney JW, Humphreys K, Harris AHS. What ecologic analyses cannot tell us about medical marijuana legalization and opioid pain medication mortality. JAMA Intern Med. 2015;175(4):655-656. doi:10.1001/jamainternmed.2014.8006.

    Bachhuber MA, Saloner B, Barry CL. What ecologic analyses cannot tell us about medical marijuana legalization and opioid pain medication mortality--reply. JAMA Intern Med. 2015;175(4):656-657. doi:10.1001/jamainternmed.2014.8027.

    Powell D, Pacula RL, Jacobson M. Do Medical Marijuana Laws Reduce Addiction and Deaths Related to Pain Killers? RAND Corporation; 2015. http://www.rand.org/content/dam/rand...AND_WR1130.pdf. Accessed April 6, 2017.

    Abrams DI, Couey P, Shade SB, Kelly ME, Benowitz NL. Cannabinoid-opioid interaction in chronic pain. Clin Pharmacol Ther. 2011;90(6):844-851. doi:10.1038/clpt.2011.188.

    Lynch ME, Clark AJ. Cannabis reduces opioid dose in the treatment of chronic non-cancer pain. J Pain Symptom Manage. 2003;25(6):496-498.

    Bradford AC, Bradford WD. Medical Marijuana Laws Reduce Prescription Medication Use In Medicare Part D. Health Aff Proj Hope. 2016;35(7):1230-1236. doi:10.1377/hlthaff.2015.1661.

    Röhrich J, Schimmel I, Zörntlein S, et al. Concentrations of delta9-tetrahydrocannabinol and 11-nor-9-carboxytetrahydrocannabinol in blood and urine after passive exposure to Cannabis smoke in a coffee shop. J Anal Toxicol. 2010;34(4):196-203.

    Cone EJ, Bigelow GE, Herrmann ES, et al. Non-smoker exposure to secondhand cannabis smoke. I. Urine screening and confirmation results. J Anal Toxicol. 2015;39(1):1-12. doi:10.1093/jat/bku116.

    Wang X, Derakhshandeh R, Liu J, et al. One Minute of Marijuana Secondhand Smoke Exposure Substantially Impairs Vascular Endothelial Function. J Am Heart Assoc. 2016;5(8). doi:10.1161/JAHA.116.003858.

    Martin CE, Longinaker N, Mark K, Chisolm MS, Terplan M. Recent trends in treatment admissions for marijuana use during pregnancy. J Addict Med. 2015;9(2):99-104. doi:10.1097/ADM.0000000000000095.

    Kline J, Hutzler M, Levin B, Stein Z, Susser M, Warburton D. Marijuana and spontaneous abortion of known karyotype. Paediatr Perinat Epidemiol. 1991;5(3):320-332.

    Wilcox AJ, Weinberg CR, Baird DD. Risk factors for early pregnancy loss. Epidemiol Camb Mass. 1990;1(5):382-385.
    Asch RH, Smith CG. Effects of delta 9-THC, the principal psychoactive component of marijuana, during pregnancy in the rhesus monkey. J Reprod Med. 1986;31(12):1071-1081.

    Campolongo P, Trezza V, Ratano P, Palmery M, Cuomo V. Developmental consequences of perinatal cannabis exposure: behavioral and neuroendocrine effects in adult rodents. Psychopharmacology (Berl). 2011;214(1):5-15. doi:10.1007/s00213-010-1892-x.

    Fried PA, Watkinson B, Gray R. A follow-up study of attentional behavior in 6-year-old children exposed prenatally to marihuana, cigarettes, and alcohol. Neurotoxicol Teratol. 1992;14(5):299-311.

    Goldschmidt L, Day NL, Richardson GA. Effects of prenatal marijuana exposure on child behavior problems at age 10. Neurotoxicol Teratol. 2000;22(3):325-336.

    Fried PA, Smith AM. A literature review of the consequences of prenatal marihuana exposure. An emerging theme of a deficiency in aspects of executive function. Neurotoxicol Teratol. 2001;23(1):1-11.

    Janisse JJ, Bailey BA, Ager J, Sokol RJ. Alcohol, tobacco, cocaine, and marijuana use: relative contributions to preterm delivery and fetal growth restriction. Subst Abuse. 2014;35(1):60-67. doi:10.1080/08897077.2013.804483.

    Hayatbakhsh MR, Flenady VJ, Gibbons KS, et al. Birth outcomes associated with cannabis use before and during pregnancy. Pediatr Res. 2012;71(2):215-219. doi:10.1038/pr.2011.25.

    Shiono PH, Klebanoff MA, Nugent RP, et al. The impact of cocaine and marijuana use on low birth weight and preterm birth: a multicenter study. Am J Obstet Gynecol. 1995;172(1 Pt 1):19-27.

    Mark K, Desai A, Terplan M. Marijuana use and pregnancy: prevalence, associated characteristics, and birth outcomes. Arch Womens Ment Health. 2016;19(1):105-111. doi:10.1007/s00737-015-0529-9.

    Schempf AH, Strobino DM. Illicit Drug Use and Adverse Birth Outcomes: Is It Drugs or Context? J Urban Health Bull N Y Acad Med. 2008;85(6):858-873. doi:10.1007/s11524-008-9315-6.

    Tobacco, drug use in pregnancy can double risk of stillbirth. https://www.nichd.nih.gov/news/relea...-drug-use.aspx. Accessed December 16, 2016.

    Marijuana Use During Pregnancy and Lactation - ACOG. ACOG. http://www.acog.org/Resources-And-Pu...-and-Lactation. Published July 2015. Accessed October 12, 2016.

    Roberson EK, Patrick WK, Hurwitz EL. Marijuana use and maternal experiences of severe nausea during pregnancy in Hawai’i. Hawaii J Med Public Health J Asia Pac Med Public Health. 2014;73(9):283-287.

    Westfall RE, Janssen PA, Lucas P, Capler R. Survey of medicinal cannabis use among childbearing women: patterns of its use in pregnancy and retroactive self-assessment of its efficacy against “morning sickness.” Complement Ther Clin Pract. 2006;12(1):27-33. doi:10.1016/j.ctcp.2005.09.006.

    Trezza V, Campolongo P, Cassano T, et al. Effects of perinatal exposure to delta-9-tetrahydrocannabinol on the emotional reactivity of the offspring: a longitudinal behavioral study in Wistar rats. Psychopharmacology (Berl). 2008;198(4):529-537. doi:10.1007/s00213-008-1162-3.

    Mereu G, Fà M, Ferraro L, et al. Prenatal exposure to a cannabinoid agonist produces memory deficits linked to dysfunction in hippocampal long-term potentiation and glutamate release. Proc Natl Acad Sci U S A. 2003;100(8):4915-4920. doi:10.1073/pnas.0537849100.

    Fried PA, Makin JE. Neonatal behavioural correlates of prenatal exposure to marihuana, cigarettes and alcohol in a low risk population. Neurotoxicol Teratol. 1987;9(1):1-7.

    de Moraes Barros MC, Guinsburg R, Mitsuhiro S, Chalem E, Laranjeira RR. Neurobehavioral profile of healthy full-term newborn infants of adolescent mothers. Early Hum Dev. 2008;84(5):281-287. doi:10.1016/j.earlhumdev.2007.07.001.

    Richardson GA, Ryan C, Willford J, Day NL, Goldschmidt L. Prenatal alcohol and marijuana exposure: effects on neuropsychological outcomes at 10 years. Neurotoxicol Teratol. 2002;24(3):309-320.

    Goldschmidt L, Day NL, Richardson GA. Effects of prenatal marijuana exposure on child behavior problems at age 10. Neurotoxicol Teratol. 2000;22(3):325-336.

    Sonon KE, Richardson GA, Cornelius JR, Kim KH, Day NL. Prenatal marijuana exposure predicts marijuana use in young adulthood. Neurotoxicol Teratol. 2015;47:10-15. doi:10.1016/j.ntt.2014.11.003.

    Perez-Reyes M, Wall ME. Presence of delta9-tetrahydrocannabinol in human milk. N Engl J Med. 1982;307(13):819-820. doi:10.1056/NEJM198209233071311.

    Astley SJ, Little RE. Maternal marijuana use during lactation and infant development at one year. Neurotoxicol Teratol. 1990;12(2):161-168

    Djulus J, Moretti M, Koren G. Marijuana use and breastfeeding. Can Fam Physician Médecin Fam Can. 2005;51:349-350.

    Budney AJ, Roffman R, Stephens RS, Walker D. Marijuana Dependence and Its Treatment. Addict Sci Clin Pract. 2007;4(1):4-16.

    Diamond G, Panichelli-Mindel SM, Shera D, Dennis M, Tims F, Ungemack J. Psychiatric Syndromes in Adolescents with Marijuana Abuse and Dependency in Outpatient Treatment. J Child Adolesc Subst Abuse. 2006;15(4):37-54. doi:10.1300/J029v15n04_02.
    "Our entire universe is contained in the mind and the spirit. We may choose not to find access to it, we may even deny its existence, but it is indeed there inside us "... Dr Alexander Shulgin June 17th, 1925-June 2nd, 2014.

  8. #58
    Join Date
    Dec 2016
    Posts
    72
    Thanks
    1
    Thanked 9 Times in 7 Posts

    Default

    Weed in NZ
    Five marijuana myths debunked: A public health expert clears the air on misinformation

    Elaine Hyshka says pot won't ruin your brain, but it probably won't help it either

    http://www.metronews.ca/news/edmonto...formation.html

    Dr. Elaine Hyshka, a member of Access to Medically Supervised Injection Services and assistant professor with the University of Albertaís school of public health. By: Kevin Maimann Metro Published on Tue Nov 21 2017 03:24:00






    In light of the Alberta government announcing its regulations for the retail sale of marijuana, Metro spoke with a public health expert Tuesday to clarify some hazy topics around legalization.

    Elaine Hyshka, professor in the University of Alberta’s school of public health and co-chair of the Minister’s Opioid Emergency Response Commission, said it’s “alarming” how much misinformation circulates on cannabis, and she helped us bust the myths.

    Myth #1: Legalization will lead to a spike in cannabis use among young people

    “What we’ve seen in other jurisdictions is that rates of use have remained fairly stable post-legalization,” Hyshka said.

    “Also, it’s important to remember that in Canada we have one of the highest rates of youth use and cannabis is illegal. So, whether it’s legal or illegal, that often doesn’t tend to have a lot of influence over whether people decide to use drugs. When it is legal, though, we have a lot more policy tools to prevent harm from those drugs.”

    Myth #2: Legalization will lead to a spike in impaired driving fatalities

    “Data from the United States where jurisdictions have legalized is showing that although there may have been a slight increase in motor vehicle collisions related to cannabis, the rate of fatal crashes has not gone up in those states relative to controls that don’t have legal cannabis,” Hyshka said, referring to a study published in the American Journal of Public Health that tracked collisions in Colorado and Washington.

    Myth #3: Cannabis is rife with health benefits

    “There are people that claim it is a panacea for every health condition and part of a wellness strategy. That is certainly not well established at all in science,” she said, adding there is strong evidence that it does help with chronic pain.

    “The science is pretty limited in terms of what has been demonstrated for therapeutic use.”

    Myth #4: Cannabis will destroy your brain

    “There are also people who claim that cannabis is going to basically damage your brain when you use it, especially if you’re young, and that it’s going to contribute to the intellectual downfall of a generation. And that’s also not true,” she said.

    While there is evidence of acute impairments in cognition and memory related to cannabis, Hyshka said studies linking the drug to declines in cognitive function “have not been well controlled.”

    Myth #5: Smoking pot in public could lead to unsuspecting passersby getting stoned

    “It’s possible that with passive exposure, you could actually end up with an elevated concentration of THC. But it has to be quite a bit – it has to be an intense exposure,” Hyshka said.

    “Even with that elevated blood concentration level, it doesn’t necessarily translate to impairment. So I would say more or less that’s not really a practical concern.”

    Related








Tags for this Thread

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts
  •